Company intelligence / Profile preview
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Lianyungang, Jiangsu, Chinahengrui.com ↗
- Ownership
- Private
- Employees
- ~24500
- Development stage
- Commercial
01
Overview
Jiangsu Hengrui Pharma is one of China’s largest pharmaceutical companies with a global presence. It focuses on innovative drug R&D in oncology and chronic disease areas. Its lead immunotherapy camrelizumab plus rivoceranib showed significant improvement in progression-free survival and overall survival versus standard-of-care in advanced hepatocellular carcinoma in a global Phase III trial. The company has an industry-leading pipeline with more than ninety programs under development as of end of 2024[1][4]. Several assets are partnered globally.
- Therapeutic areas
- OncologyMetabolic DisordersImmunologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculesmonoclonal antibodies (mAbs)antibody-drug conjugates (ADCs)biological productschemical drugs
- Industry
- Pharma
02
Drug pipeline
14 assets13 more assets in the full pipeline.
Request access →03
Partnerships
Merck KGaA/DarmstadtMerck & Co./MSDCStone Pharmaceuticals
Beyond the preview
Go deeper on Jiangsu Hengrui Pharmaceuticals Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangsu Hengrui Pharmaceuticals Co., Ltd..